Emervel Volume (1x1ml)
Minimum Qty: 2
How does Emervel Volume (1x1ml) work?
Emervel Volume (1x1ml) is a gel filler with added 0.3% lidocaine to increase comfort and reduce pain at the injection site during treatment.
Designed to create and intense high volume lifting effect in the face. The ageing process can result in loss of face volume in cheekbones and the chin, which can then be restored by Emervel Volume.
Emervel products contain the active ingredient cross linked, non- animal based Butanediol Diglycidyl Ether (BDDE). Optimal Balance Technology?? allows Emervel fillers to integrate smoothly into the skin, giving a higher acceptance rate by the patient’s skin. OBT ensures an optimal balance between the level of cross-linking and gel calibration that exists due to an equilibrium concentration of hyaluronic acid
What’s in the box?
Hyaluronic Acid (non-cross linked) containing 0.3% lidocaine
1 x 2.0ml syringes
What are the benefits of Emervel Volume?
Emervel Volume can be used to restore volume in many places of the face, specifically in:
Cheeks, zygomatic area
Jaw line modelling
How long will results last for?
Results are safe and instant from the first treatment. The overall effects will last from 6 to 9 months and even up to one year depending on the individuals skin type factors, such as age, lifestyle and technique used but the medical professional.
IMPERIAL SKIN BEAUTY are a European online store based. We have many years of know-how and experience within the aesthetic beauty industry and we offer Botulinums, Glutathione, Placenta, Mesotherapy, Dermal fillers and orthopedic distributor, and other medical devices at competitive prices to licensed clinics worldwide. The new trend among clinics is that they typically buy 70% at the local official distributor (To receive marketing support, courses, etc.) and 30% as parallel import – to maximize their profit and increase the bottom line.
IMPERIAL SKIN BEAUTY offer great-value generics, without ever compromising on quality. The products we offer are manufactured by leading pharmaceutical companies .